Moreover, in mouse models of melanoma and breast cancer IL-9 released in the TME forces macrophages to release the chemokines MIP-1 and CXCR3, which in turn attract T cells, thereby enhancing anti-tumor immune responses (127). This evidence concerns the gene IL9 and neoplasm.